Form 4: Bio-Rad Laboratories Executive Reports Stock Transactions
SEC Form 4 Filing
Courtney C. Enloe, EVP, General Counsel & Secretary of Bio-Rad Laboratories, reports acquisition and disposal of Bio-Rad A Common Stock due to vesting of restricted stock units and tax withholding.
Summary
- On April 24, 2025, Courtney C. Enloe, EVP, General Counsel & Secretary of Bio-Rad Laboratories, reported transactions involving Bio-Rad A Common Stock.
- Enloe acquired 186 shares of Class A common stock upon the vesting of restricted stock units.
- A portion of shares were disposed of to cover tax obligations related to the vesting of restricted stock units.
- Enloe also reported holding 558 derivative securities beneficially owned following reported transactions.
- The reporting person was granted 744 restricted stock units on April 24, 2024, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation. There are no indications of significant positive or negative developments.
Positives
- The vesting of restricted stock units indicates a form of compensation and alignment of the executive's interests with the company's performance.
Future Outlook
The executive holds 558 restricted stock units that will vest in future installments, potentially leading to further stock acquisitions.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor executive compensation and potential alignment with shareholder interests.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units as a way to incentivize performance and retain key personnel.
- The vesting schedules and terms of these units are generally comparable to those offered by similar companies in the biotechnology and life sciences industries.
- Companies like Danaher, Thermo Fisher Scientific, and Agilent Technologies also utilize stock-based compensation for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the standard compensation practices for company executives.
Key Dates
| Date | Description |
|---|---|
| 04/24/2024 | Reporting person was granted 744 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 03/31/2025 | Includes 5.5730 shares acquired under the Bio-Rad Employee Stock Purchase Plan. |
| 04/24/2025 | Date of transaction: acquisition of 186 shares of Class A common stock on the vesting of restricted stock units and disposal of 67 shares for tax obligations. |
| 04/25/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Bio-Rad Laboratories, Enloe, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.